{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:07:43Z","timestamp":1774559263696,"version":"3.50.1"},"reference-count":48,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3892\/or.2015.4001","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T09:38:46Z","timestamp":1432114726000},"page":"477-487","source":"Crossref","is-referenced-by-count":15,"title":["The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis"],"prefix":"10.3892","volume":"34","author":[{"given":"KE-WANG","family":"LUO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GRACE GAR-LEE","family":"YUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHUN-HAY","family":"KO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SI","family":"GAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JULIA KIN-MING","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GANG","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KWOK-PUI","family":"FUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PING-CHUNG","family":"LEUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CLARA BIK-SAN","family":"LAU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,5,20]]},"reference":[{"key":"key20180107212430_b1-or-34-01-0477","volume-title":"Advances in Food Science and Technology","author":"Hara","year":"1990"},{"key":"key20180107212430_b2-or-34-01-0477","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.296.10.1255","article-title":"Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study","volume":"296","author":"Kuriyama","year":"2006","journal-title":"JAMA"},{"key":"key20180107212430_b3-or-34-01-0477","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/jmf.2006.9.451","article-title":"Green tea extract thermogenesis-induced weight loss by epigallocat-echin gallate inhibition of catechol-O-methyltransferase","volume":"9","author":"Shixian","year":"2006","journal-title":"J Med Food"},{"key":"key20180107212430_b4-or-34-01-0477","first-page":"317","article-title":"Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo","volume":"90","author":"Nakazato","year":"2005","journal-title":"Haematologica"},{"key":"key20180107212430_b5-or-34-01-0477","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-05-1145","article-title":"Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study","volume":"66","author":"Bettuzzi","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107212430_b6-or-34-01-0477","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-824X-5-9","article-title":"EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1\u03b1 and NF\u03baB, and VEGF expression","volume":"5","author":"Gu","year":"2013","journal-title":"Vasc Cell"},{"key":"key20180107212430_b7-or-34-01-0477","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.clnu.2013.03.008","article-title":"Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy","volume":"32","author":"Lecumberri","year":"2013","journal-title":"Clin nutr"},{"key":"key20180107212430_b8-or-34-01-0477","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.fct.2011.03.033","article-title":"Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro","volume":"49","author":"Qiao","year":"2011","journal-title":"Food Chem Toxicol"},{"key":"key20180107212430_b9-or-34-01-0477","first-page":"111","article-title":"Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer","volume":"37","author":"Liang","year":"2010","journal-title":"Int J Oncol"},{"key":"key20180107212430_b10-or-34-01-0477","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/BSR20090143","article-title":"(\u2212)-Epigallocatechin-3-gallate down-regulates EGfr, MMP-2, MMP-9 and EMMPrIn and inhibits the invasion of MCf-7 tamoxifen-resistant cells","volume":"31","author":"Farabegoli","year":"2011","journal-title":"Biosci Rep"},{"key":"key20180107212430_b11-or-34-01-0477","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jnutbio.2013.11.013","article-title":"Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice","volume":"25","author":"Luo","year":"2014","journal-title":"J Nutr Biochem"},{"key":"key20180107212430_b12-or-34-01-0477","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.25051","article-title":"Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model","volume":"127","author":"Labrinidis","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107212430_b13-or-34-01-0477","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/bcr412","article-title":"Direct effects of bisphosphonates on breast cancer cells","volume":"4","author":"Senaratne","year":"2002","journal-title":"Breast Cancer Res"},{"key":"key20180107212430_b14-or-34-01-0477","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S8756-3282(03)00223-0","article-title":"Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis","volume":"33","author":"Evdokiou","year":"2003","journal-title":"Bone"},{"key":"key20180107212430_b15-or-34-01-0477","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107212430_b16-or-34-01-0477","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10549-010-1183-6","article-title":"Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance","volume":"124","author":"Zhao","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107212430_b17-or-34-01-0477","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/1471-2407-11-403","article-title":"Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving \u2018metronomic\u2019 zoledronic acid","volume":"11","author":"Zhao","year":"2011","journal-title":"BMC Cancer"},{"key":"key20180107212430_b18-or-34-01-0477","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jnci\/djk054","article-title":"Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis","volume":"99","author":"Daubin\u00e9","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"key20180107212430_b19-or-34-01-0477","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4161\/cbt.10.6.12611","article-title":"Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial","volume":"10","author":"Facchini","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"key20180107212430_b20-or-34-01-0477","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2013.07.024","article-title":"Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models","volume":"339","author":"Luo","year":"2013","journal-title":"Cancer Lett"},{"key":"key20180107212430_b21-or-34-01-0477","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jfca.2008.05.002","article-title":"An improved HPLC method for simultaneous determination of phenolic compounds, purine alkaloids and theanine in Camellia species","volume":"21","author":"Peng","year":"2008","journal-title":"J Food Compos Anal"},{"key":"key20180107212430_b22-or-34-01-0477","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1368-8375(99)00028-7","article-title":"Prognostic value of apoptotic index in cutaneous basal cell carcinomas of head and neck","volume":"35","author":"Staibano","year":"1999","journal-title":"Oral Oncol"},{"key":"key20180107212430_b23-or-34-01-0477","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.yexcr.2008.10.020","article-title":"Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitro","volume":"315","author":"Vigl","year":"2009","journal-title":"Exp Cell Res"},{"key":"key20180107212430_b24-or-34-01-0477","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1158\/0008-5472.CAN-06-3645","article-title":"Phenethyl isothiocyanate inhibits angio-genesis in vitro and ex vivo","volume":"67","author":"Xiao","year":"2007","journal-title":"Cancer res"},{"key":"key20180107212430_b25-or-34-01-0477","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jnci.2012.06.002","article-title":"Bone metastasis in breast cancer: The story of RANK-ligand","volume":"24","author":"Azim","year":"2012","journal-title":"J Egypt Natl Cancer Inst"},{"key":"key20180107212430_b26-or-34-01-0477","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mrrev.2013.01.002","article-title":"Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview","volume":"753","author":"Chaudhary","year":"2013","journal-title":"Mutat Res"},{"key":"key20180107212430_b27-or-34-01-0477","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nchembio817","article-title":"Systems biology and combination therapy in the quest for clinical efficacy","volume":"2","author":"Fitzgerald","year":"2006","journal-title":"Nat Chem Biol"},{"key":"key20180107212430_b28-or-34-01-0477","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/msb4100133","article-title":"Networks from drug-drug surfaces","volume":"3","author":"Yeh","year":"2007","journal-title":"Mol Syst Biol"},{"key":"key20180107212430_b29-or-34-01-0477","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1749-8546-4-25","article-title":"Cancer patients\u2019 attitudes towards Chinese medicine: A Hong Kong survey","volume":"4","author":"Lam","year":"2009","journal-title":"Chin Med"},{"key":"key20180107212430_b30-or-34-01-0477","first-page":"772","article-title":"Treatment for advanced gastric cardia carcinoma in 26 cases of integrated traditional Chinese and Western Medicine","volume":"25","author":"Wang","year":"2004","journal-title":"Shanxi J Tradit Chin Med"},{"key":"key20180107212430_b31-or-34-01-0477","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/187221312798889310","article-title":"Efficacy of Yun zhi (Coriolus versicolor) on survival in cancer patients: Systematic review and meta-analysis","volume":"6","author":"Eliza","year":"2012","journal-title":"Recent Pat Inflamm allergy Drug Discov"},{"key":"key20180107212430_b32-or-34-01-0477","first-page":"4851","article-title":"Epigallo-catechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells","volume":"32","author":"Mazumder","year":"2012","journal-title":"Anticancer Res"},{"key":"key20180107212430_b33-or-34-01-0477","first-page":"445","article-title":"The combination of cytotoxic and molecularly targeted therapies - can it be done","volume":"1","author":"Jackman","year":"2004","journal-title":"Drug Discov Today"},{"key":"key20180107212430_b34-or-34-01-0477","first-page":"1486","article-title":"Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines","volume":"58","author":"Pulaski","year":"1998","journal-title":"Cancer Res"},{"key":"key20180107212430_b35-or-34-01-0477","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br J Cancer"},{"key":"key20180107212430_b36-or-34-01-0477","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1158\/1078-0432.CCR-04-1976","article-title":"Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems","volume":"11","author":"Baliga","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107212430_b37-or-34-01-0477","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1021\/jf901545u","article-title":"Effects of tea catechins, epigallocatechin, gallocatechin, and gallocatechin gallate, on bone metabolism","volume":"57","author":"Ko","year":"2009","journal-title":"J Agric Food Chem"},{"key":"key20180107212430_b38-or-34-01-0477","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/mol.109.057877","article-title":"Epigallo-catechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal","volume":"77","author":"Lee","year":"2010","journal-title":"Mol Pharmacol"},{"key":"key20180107212430_b39-or-34-01-0477","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00223-012-9584-7","article-title":"(\u2212)-Epigallocathechin-3-gallate, an aMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption","volume":"90","author":"Lee","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"key20180107212430_b40-or-34-01-0477","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/0002512-200825110-00007","article-title":"Zoledronic acid: A review of its use in the treatment of osteoporosis","volume":"25","author":"Deeks","year":"2008","journal-title":"Drugs aging"},{"key":"key20180107212430_b41-or-34-01-0477","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","article-title":"Protein prenylation: Molecular mechanisms and functional consequences","volume":"65","author":"Zhang","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"key20180107212430_b42-or-34-01-0477","first-page":"2056","article-title":"Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: A potential marker for bone formation and response to GH therapy","volume":"82","author":"Tobiume","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107212430_b43-or-34-01-0477","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2009.06.003","article-title":"Zoledronic acid induces apoptosis and changes the TRAIL\/OPG ratio in breast cancer cells","volume":"287","author":"Rachner","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180107212430_b44-or-34-01-0477","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/aps.2011.139","article-title":"Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro","volume":"33","author":"Zhou","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107212430_b45-or-34-01-0477","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.acthis.2006.03.008","article-title":"Cellular basis of cancer metastasis: A review of fundamentals and new advances","volume":"108","author":"Oppenheimer","year":"2006","journal-title":"Acta Histochem"},{"key":"key20180107212430_b46-or-34-01-0477","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/1078-0432.CCR-03-0325","article-title":"Zoledronic acid inhibits visceral metastases in the 4T1\/luc mouse breast cancer model","volume":"10","author":"Hiraga","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107212430_b47-or-34-01-0477","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/1471-2407-6-225","article-title":"Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer","volume":"6","author":"Orlando","year":"2006","journal-title":"BMC Cancer"},{"key":"key20180107212430_b48-or-34-01-0477","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0300-2977(01)00140-1","article-title":"Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma","volume":"59","author":"de Weerdt","year":"2001","journal-title":"Neth J Med"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4001\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T03:42:12Z","timestamp":1717904532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,5,20]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3892\/or.2015.4001"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4001","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,20]]}}}